rs1133189
Positions:
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BA1
The NM_001358263.1(HK1):āc.90C>Gā(p.Leu30=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.363 in 1,610,334 control chromosomes in the GnomAD database, including 109,887 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.36 ( 10109 hom., cov: 31)
Exomes š: 0.36 ( 99778 hom. )
Consequence
HK1
NM_001358263.1 synonymous
NM_001358263.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.347
Genes affected
HK1 (HGNC:4922): (hexokinase 1) Hexokinases phosphorylate glucose to produce glucose-6-phosphate, the first step in most glucose metabolism pathways. This gene encodes a ubiquitous form of hexokinase which localizes to the outer membrane of mitochondria. Mutations in this gene have been associated with hemolytic anemia due to hexokinase deficiency. Alternative splicing of this gene results in several transcript variants which encode different isoforms, some of which are tissue-specific. [provided by RefSeq, Apr 2016]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -19 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.39).
BP6
Variant 10-69343841-C-G is Benign according to our data. Variant chr10-69343841-C-G is described in ClinVar as [Benign]. Clinvar id is 439787.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr10-69343841-C-G is described in Lovd as [Benign].
BP7
Synonymous conserved (PhyloP=0.347 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.398 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
HK1 | NM_001358263.1 | c.90C>G | p.Leu30= | synonymous_variant | 5/21 | ENST00000643399.2 | NP_001345192.1 | |
HK1 | NM_000188.3 | c.78C>G | p.Leu26= | synonymous_variant | 2/18 | ENST00000359426.7 | NP_000179.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
HK1 | ENST00000643399.2 | c.90C>G | p.Leu30= | synonymous_variant | 5/21 | NM_001358263.1 | ENSP00000494664 | |||
HK1 | ENST00000359426.7 | c.78C>G | p.Leu26= | synonymous_variant | 2/18 | 1 | NM_000188.3 | ENSP00000352398 | P1 |
Frequencies
GnomAD3 genomes AF: 0.357 AC: 54245AN: 151800Hom.: 10103 Cov.: 31
GnomAD3 genomes
AF:
AC:
54245
AN:
151800
Hom.:
Cov.:
31
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.314 AC: 78903AN: 251444Hom.: 13691 AF XY: 0.317 AC XY: 43142AN XY: 135892
GnomAD3 exomes
AF:
AC:
78903
AN:
251444
Hom.:
AF XY:
AC XY:
43142
AN XY:
135892
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.363 AC: 529833AN: 1458416Hom.: 99778 Cov.: 34 AF XY: 0.361 AC XY: 262098AN XY: 725694
GnomAD4 exome
AF:
AC:
529833
AN:
1458416
Hom.:
Cov.:
34
AF XY:
AC XY:
262098
AN XY:
725694
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.357 AC: 54285AN: 151918Hom.: 10109 Cov.: 31 AF XY: 0.352 AC XY: 26147AN XY: 74236
GnomAD4 genome
AF:
AC:
54285
AN:
151918
Hom.:
Cov.:
31
AF XY:
AC XY:
26147
AN XY:
74236
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
814
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:3
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 31, 2024 | - - |
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Nov 30, 2023 | - - |
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Retinitis pigmentosa 79 Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Hemolytic anemia due to hexokinase deficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Neurodevelopmental disorder with visual defects and brain anomalies Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Charcot-Marie-Tooth disease type 4G Benign:1
Benign, criteria provided, single submitter | clinical testing | Genome-Nilou Lab | Aug 10, 2021 | - - |
Retinal dystrophy Benign:1
Benign, criteria provided, single submitter | research | Dept Of Ophthalmology, Nagoya University | Oct 01, 2023 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
RBP_binding_hub_radar
RBP_regulation_power_radar
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at